Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and functional analysis of energy metabolism and pyroptosis-related genes in diabetic nephropathy. | Heliyon | 2025 | 39995931 | PubTator, text mining | PubMed |
| Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer. | Front Immunol | 2025 | 39967665 | PubTator, text mining | PubMed |
| Identification of genes involved in energy metabolism in preeclampsia and discovery of early biomarkers. | Front Immunol | 2025 | 39967661 | PubTator, text mining | PubMed |
| FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice. | Nat Commun | 2025 | 39955281 | PubTator, text mining | PubMed |
| Omega-3 polyunsaturated fatty acids modify glucose metabolism in THP-1 monocytes. | Biochem Cell Biol | 2025 | 39899814 | PubTator, text mining | PubMed |
| Identification and analysis of prognostic ion homeostasis characteristics in kidney renal clear cell carcinoma. | Heliyon | 2025 | 39897849 | PubTator, text mining | PubMed |
| Differential gene expression analysis and machine learning identified structural, TFs, cytokine and glycoproteins, including SOX2, TOP2A, SPP1, COL1A1, and TIMP1 as potential drivers of lung cancer. | Biomarkers | 2025 | 39888730 | PubTator, text mining | PubMed |
| A Mitochondria-Related Signature in Diffuse Large B-Cell Lymphoma: Prognosis, Immune and Therapeutic Features. | Cancer Med | 2025 | 39811936 | PubTator, text mining | PubMed |
| Effects of seven days' fasting on physical performance and metabolic adaptation during exercise in humans. | Nat Commun | 2025 | 39747857 | PubTator, text mining | PubMed |
| Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated JAK-STAT3 pathway. | Int Immunopharmacol | 2025 | 39724732 | PubTator, text mining | PubMed |
| Multi-omics insights into the pathogenesis of diabetic cardiomyopathy: epigenetic and metabolic profiles. | Epigenomics | 2025 | 39623870 | PubTator, text mining | PubMed |
| Estrogen Regulates Mitochondrial Activity Through Inducing Brain-Derived Neurotrophic Factor Expression in Skeletal Muscle. | J Cell Physiol | 2025 | 39530291 | PubTator, text mining | PubMed |
| Identification and Experimental Verification of PDK4 as a Potential Biomarker for Diagnosis and Treatment in Rheumatoid Arthritis. | Mol Biotechnol | 2025 | 39466354 | PubTator, text mining | PubMed |
| Actions of thyroid hormones and thyromimetics on the liver. | Nat Rev Gastroenterol Hepatol | 2025 | 39420154 | PubTator, text mining | PubMed |
| Responses to Exercise with Low Carbohydrate Availability on Muscle Glycogen and Cell Signaling: A Systematic Review and Meta-analysis. | Sports Med | 2025 | 39352665 | PubTator, text mining | PubMed |
| Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification. | Curr Med Chem | 2025 | 39108112 | PubTator, text mining | PubMed |
| Identification of hub genes associated with pyroptosis in diabetic nephropathy patients using integrated bioinformatic analysis. | Int Urol Nephrol | 2025 | 39028495 | PubTator, text mining | PubMed |
| Characterizing 24-Hour Skeletal Muscle Gene Expression Alongside Metabolic and Endocrine Responses Under Diurnal Conditions. | J Clin Endocrinol Metab | 2025 | 38779872 | PubTator, text mining | PubMed |
| Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism. | Cell Commun Signal | 2024 | 39707386 | PubTator, text mining | PubMed |
| Correction: Gao et al. High Expression of PDK4 Could Play a Potentially Protective Role by Attenuating Oxidative Stress after Subarachnoid Hemorrhage. J. Clin. Med. 2022, 11, 3974. | J Clin Med | 2024 | 39685950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=10